Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 16 Myelodysplastic Syndromes 9 Lung Neoplasms 5 Myeloproliferative Disorders 4 Leukemia, Myelomonocytic, Chronic 4 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Stomatitis 2 Primary Myelofibrosis 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mucositis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Monocytic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Prostate Cancer Metastatic 1 Polycythemia Vera 1

Interventions

etrolizumab 5 Infliximab 2 Adalimumab 2 golimumab 1 Papillomavirus Vaccines 1 Mesalamine 1 Injections 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Andrographis paniculata extract 1 ABX464 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colitis, Ulcerative × Injections × Clear all

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡